Article Details
Retrieved on: 2023-09-18 12:17:49
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Ojjaara will likely put pressure on uptake of Jakafi as a first-line treatment for myelofibrosis, Truist Securities analysts wrote in a note Friday.
Article found on: www.morningstar.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here